1 / 5

Multiple Sclerosis

Multiple Sclerosis. Incidence. 85,000 patient in UK Cases present between 20-40yrs of age Twice as many females Not a fatal condition, most patients have a normal life span 2/3rds of patients don’t get a major disability and are able to walk with the use of an aid. Characteristics.

beyla
Télécharger la présentation

Multiple Sclerosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Multiple Sclerosis

  2. Incidence • 85,000 patient in UK • Cases present between 20-40yrs of age • Twice as many females • Not a fatal condition, most patients have a normal life span • 2/3rds of patients don’t get a major disability and are able to walk with the use of an aid

  3. Characteristics • Relapsing remitting (85% of cases)…acute flare ups with partial or complete remissions • Primary progressive: progressive disease with no remissions (10%) • Secondary progressive: start as relapsing remitting followed by steady progression (50% of RR followed this pattern before DMDs • Progressive relapsing:steady worsening from outset with acute relapses with or without recovery, continuous progression between relapses

  4. Treatment • Disease modifying drugs decrease relapse rate in RR by up to 1/3rd and some trials have shown decreased severity of relapses. • Beta interferon is indicated for SP when relapses are the cause of increasing disability • Beta interferon doesn’t help those with severe disabilities • No treatment for PP

  5. Treatment contd. • Beta interferon can cause flu like symptoms in first 3/12 • Neutralising antibodies can be provoked by beta interferon thereby blocking the effect of the drug • Copaxone can cause chest tightness, flushing and sweating • When to start Rx ??

More Related